|
|
|
Corporate Profile: Hemispherx
Biopharma
| Summary: |
HEMISPHERx
BIOPHARMA, INC has devoted nearly three decades
to exploring, understanding, and mastering the mechanism
of RNA technology. The Company's longevity as a
biomedical research and drug development institution,
coupled with its record of tremendous enduring scientific
achievement is evidence of HEB's long-term commitment
to this promising new class of drugs and to bring
new therapeutic choices to the global community. |
| Address (HQ): |
1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103 |
783 Jersey Avenue
New Brunswick, NJ 08901 |
| Phone #'s (HQ): |
| Main |
(215) 988-0080 |
(732) 249-3250 |
| Human Resources |
not known |
not known |
| Investor Relations |
not known |
not known |
| Fax #'s (HQ): |
| Main |
(215) 988-1739 |
(732) 249-6895 |
| Human Resources |
(215) 988-1739 |
not known |
| Investor Relations |
not known |
not known |
| Financial
information: |
| HEB |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
